Recent Finacing
Recent Raise
Replicate Bioscience develops self‑replicating RNA therapeutics using virally derived vectors to enable prolonged protein expression, lower dosing, selective immune activation/evasion, and synthetic immune‑lethality for solid tumors and autoimmune disorders.
